TP53BP1 and thyroid gland carcinoma: Our results concur with those obtained by Jensen and colleagues, who demonstrated in thyroid cancer cells that similar doses of NFV than the ones used in our study induced the expression of γH2AX and p53BP1, indicating DNA damage [41].